Nearly three-quarters of the 73 million low-income Americans on Medicaid are now in managed care, in which states pay health insurers fixed monthly amounts for each enrollee to cover the range of services they need.
Under this system, keeping patients as healthy as possible is one way to make money. Another is to deny or skimp on services.
Increasingly, Medicaid plans outsource the work of managing patients' health and medical treatment to subcontractors like Agilon — passing along a share of the government money coupled with the financial risk posed by a fixed budget.
These firms can be powerful gatekeepers. They run physician groups, bear responsibility for forming doctor networks and judge whether a request for care is necessary.
Agilon is a big player in California — doing business with insurers such as Molina Healthcare and Blue Shield of California — and it's now expanding in other states like Texas and Ohio.
Primary Provider Management Co. ran several medical groups, including Vantage Medical Group with more than 5,000 physicians across Southern California. By building off PPMC's base of Medicaid enrollees in California, the New York private equity firm that owns a majority stake in Agilon — Clayton, Dubilier & Rice — sought to coordinate care in Medicaid and Medicare Advantage plans across the country. (CD&R did not respond to interview requests.)
For several years, the problems at PPMC, and then Agilon, went undetected. Then, in early 2018, Agilon disclosed to the California Department of Managed Health Care its discovery that employees had been altering records prepared for auditors, which it said was not known to top management.
According to an internal report, completed in May and obtained by KHN, staffers had been falsifying documents since at least 2014 to pass audits by health plans. Employees were changing dates, for example, to cover up delays or withholding certain files so they couldn't be reviewed.
That same month, an anonymous whistleblower sent a letter to health plans and government officials, urging them to investigate "illegal, unethical" conduct at the firm. "Senior management delays treatments for cancer patients without any regard of patient's well-being, to save their dollars," the whistleblower wrote in a two-page letter reviewed by KHN. "They brag about how profitable we are."
In response to the allegations raised by the whistleblower and state, Agilon opened another internal investigation. That second report, finished in June, found inadequate staffing to handle the volume of work, various shortcuts and practices outside industry "norms" and improperly denied claims. Both internal reports were released to the state.
A top official Inland Empire Health Plan, one of the largest Medicaid insurers in the country, said the plan also looked into Agilon's conduct and found instances in which its patients were harmed.
In an interview, Inland Empire CEO Bradley Gilbert said Agilon denied a patient's transfusions for anemia, causing the person to be hospitalized. It also improperly denied cardiac rehabilitation to a patient recovering from a heart attack, he said. Inland Empire canceled its contract with Agilon's Vantage Medical Group in August, he said.